MediPharm Labs’ Board Continues Value Destruction for Shareholders with Sale of Hope Facility Complete Incompetence at the Board Level Results in Fire Sale of Treasured MediPharm Asset, the Hope Facility, to a Competitor…
MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder MediPharm Labs responds to allegations from dissident shareholder Apollo, intentionally or recklessly fabricated as part of its campaign of misinformation.…
Apollo Capital Comments on MediPharm Labs’ Failure to Respond to Reasonable Offer to Ensure Fair, Lawful and Transparent 2025 Annual Meeting MediPharm Labs Board Continues to Obstruct the Appointment and Oversight of an Independent Chair…
Apollo Capital Issues a With Prejudice Offer to MediPharm Labs and Its Board of Directors to Ensure Shareholder Rights Are Protected at the 2025 Annual Meeting Believes the Board Continues to Take Oppressive Actions Which Fundamentally Disregard the Rights and Interests of Shareholders…
Market Might Still Lack Some Conviction On MediPharm Labs Corp. (TSE:LABS) Even After 31% Share Price Boost Despite an already strong run, MediPharm Labs Corp. ( TSE:LABS ) shares have been powering on, with a gain of…